Atypicals for Non-psychotic disorders

You may have noticed a recent torrent of FDA approvals and clinical trials for atypical antipsychotics in every disorder under the sun–except psychosis. Is this simply an effort by the sponsoring companies to get us to prescribe more antipsychotics? Or are these drugs truly effective for non-psychotic disorders? What’s the quality of the evidence?

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.